Published in Vaccine on June 28, 2006
Memory CD8 T cell responses exceeding a large but definable threshold provide long-term immunity to malaria. Proc Natl Acad Sci U S A (2008) 2.62
A review of malaria vaccine clinical projects based on the WHO rainbow table. Malar J (2012) 1.87
Cross-priming of cytotoxic T cells dictates antigen requisites for modified vaccinia virus Ankara vector vaccines. J Virol (2007) 1.30
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine. Vaccine (2011) 1.25
Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals. J Infect Dis (2014) 1.09
Protection of rhesus monkeys by a DNA prime/poxvirus boost malaria vaccine depends on optimal DNA priming and inclusion of blood stage antigens. PLoS One (2007) 1.06
The evolution of poxvirus vaccines. Viruses (2015) 1.02
Safety and immunogenicity of recombinant poxvirus HIV-1 vaccines in young adults on highly active antiretroviral therapy. Vaccine (2008) 1.02
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations. Mol Ther (2014) 0.96
A phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS. PLoS One (2014) 0.86
Avipoxviruses: infection biology and their use as vaccine vectors. Virol J (2011) 0.86
Malaria vaccine adjuvants: latest update and challenges in preclinical and clinical research. Biomed Res Int (2013) 0.78
The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med (2001) 37.70
Common west African HLA antigens are associated with protection from severe malaria. Nature (1991) 9.43
Averting a malaria disaster. Lancet (1999) 9.40
Mortality and morbidity from malaria in Gambian children after introduction of an impregnated bednet programme. Lancet (1995) 8.71
TNF concentration in fatal cerebral, non-fatal cerebral, and uncomplicated Plasmodium falciparum malaria. Lancet (1990) 6.32
Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet (1971) 6.05
Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc Natl Acad Sci U S A (1989) 5.03
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial. Lancet (2001) 5.01
Secret government: the Scott report. BMJ (1996) 4.83
Antibodies to blood stage antigens of Plasmodium falciparum in rural Gambians and their relation to protection against infection. Trans R Soc Trop Med Hyg (1990) 4.70
Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58
HIV-1 regulator of virion expression (Rev) protein binds to an RNA stem-loop structure located within the Rev response element region. Cell (1990) 4.50
Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature (1994) 4.37
Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature (1992) 3.93
HIV-1 tat protein stimulates transcription by binding to a U-rich bulge in the stem of the TAR RNA structure. EMBO J (1990) 3.92
Constitutive and regulated alpha-secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A (1999) 3.85
Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis (2001) 3.75
Rapid bacteriological diagnosis of pyogenic meningitis by latex agglutination. Lancet (1974) 3.64
Overlap in the clinical features of pneumonia and malaria in African children. Trans R Soc Trop Med Hyg (1994) 3.58
Association between an MHC class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med (1995) 3.54
Clinical immunity to Plasmodium falciparum malaria is associated with serum antibodies to the 19-kDa C-terminal fragment of the merozoite surface antigen, PfMSP-1. J Infect Dis (1996) 3.49
Association of malaria parasite population structure, HLA, and immunological antagonism. Science (1998) 3.40
Respiratory syncytial virus infection in tropical and developing countries. Trop Med Int Health (1998) 3.38
Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med (1999) 3.38
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis (2001) 3.36
Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria. Q J Med (1977) 3.27
Rotator-cuff changes in asymptomatic adults. The effect of age, hand dominance and gender. J Bone Joint Surg Br (1995) 3.25
Autoimmune disease and parasitic infections in Nigerians. Lancet (1968) 3.22
Naturally acquired cellular and humoral immune responses to the major merozoite surface antigen (PfMSP1) of Plasmodium falciparum are associated with reduced malaria morbidity. Parasite Immunol (1992) 3.12
Immunosuppression in children with malaria. Lancet (1972) 3.11
A principal target of human immunity to malaria identified by molecular population genetic and immunological analyses. Nat Med (2000) 3.06
High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci U S A (1999) 3.03
Evaluation of an algorithm for the integrated management of childhood illness in an area with seasonal malaria in the Gambia. Bull World Health Organ (1997) 3.00
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet (1999) 2.83
Possible role of a B-cell mitogen in hypergammaglobulinaemia in malaria and trypanosomiasis. Lancet (1974) 2.83
Validity of fan-beam dual-energy X-ray absorptiometry for measuring fat-free mass and leg muscle mass. Health, Aging, and Body Composition Study--Dual-Energy X-ray Absorptiometry and Body Composition Working Group. J Appl Physiol (1985) (1999) 2.81
Garlic or jalapeño peppers for treatment of Helicobacter pylori infection. Am J Gastroenterol (1999) 2.77
Pneumococcal antigen in lobar pneumonia. J Clin Pathol (1975) 2.75
The etiology of pneumonia in malnourished and well-nourished Gambian children. Pediatr Infect Dis J (1994) 2.73
Evidence for inhibition of fusion of lysosomal and prelysosomal compartments with phagosomes in macrophages infected with pathogenic Mycobacterium avium. Infect Immun (1986) 2.71
Carriage of pneumococci after pneumococcal vaccination. Lancet (1996) 2.69
Placental malaria. I. Pathological classification. Histopathology (1993) 2.62
Allergic complications of meningococcal disease. II. Immunological investigations. Br Med J (1973) 2.61
Prognostic performance and customization of the SAPS II: results of a multicenter Austrian study. Simplified Acute Physiology Score. Intensive Care Med (1999) 2.61
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
The safety of the combination artesunate and pyrimethamine-sulfadoxine given during pregnancy. Trans R Soc Trop Med Hyg (2001) 2.54
Assessment of clinical criteria for identification of severe acute lower respiratory tract infections in children. Lancet (1989) 2.51
Noninvasive assessment of bone mineral and structure: state of the art. J Bone Miner Res (1996) 2.47
Molecular cloning of the receptor for human antidiuretic hormone. Nature (1992) 2.44
Deaths in infancy and early childhood in a well-vaccinated, rural, West African population. Ann Trop Paediatr (1987) 2.42
Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42
IgG3 antibodies to Plasmodium falciparum merozoite surface protein 2 (MSP2): increasing prevalence with age and association with clinical immunity to malaria. Am J Trop Med Hyg (1998) 2.41
Tumour necrosis factor production in Falciparum malaria and its association with schizont rupture. Clin Exp Immunol (1989) 2.41
The limitations of verbal autopsy in a malaria-endemic region. Ann Trop Paediatr (1994) 2.40
Permethrin-treated bed nets (mosquito nets) prevent malaria in Gambian children. Trans R Soc Trop Med Hyg (1988) 2.40
Treponemal infection and the outcome of pregnancy in a rural area of The Gambia, west Africa. J Infect Dis (1992) 2.39
Impairment of the immune response to vaccination after acute malaria. Lancet (1978) 2.39
Ankylosing spondylitis in West Africans--evidence for a non-HLA-B27 protective effect. Ann Rheum Dis (1997) 2.33
Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry. Virology (1983) 2.30
Pallor as a clinical sign of severe anaemia in children: an investigation in the Gambia. Bull World Health Organ (1997) 2.28
Complement and meningococcal infection. Br Med J (1976) 2.28
Evidence for a malaria mitogen in human malaria. Nature (1975) 2.25
Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet (2000) 2.24
Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis (1987) 2.23
Allertic complications of meningococcal disease. I. Clinical aspects. Br Med J (1973) 2.20
Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression. Nat Med (1998) 2.12
Changes in the pattern of infant and childhood mortality in upper river division, The Gambia, from 1989 to 1993. Trop Med Int Health (1997) 2.09
Immunosuppression in murine malaria. II. The effect on reticulo-endothelial and germinal centre function. Clin Exp Immunol (1971) 2.08
The prediction of visceral fat by dual-energy X-ray absorptiometry in the elderly: a comparison with computed tomography and anthropometry. Int J Obes Relat Metab Disord (2002) 2.08
Malaria susceptibility and CD36 mutation. Nature (2000) 2.07
Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06
Congenital megalourethra: prenatal diagnosis and postnatal/autopsy findings in 10 cases. Ultrasound Obstet Gynecol (2011) 2.01
Polyarthritis in Western Nigeria. I. Rheumatoid arthritis. Ann Rheum Dis (1969) 2.01
Risk factors for mortality from acute lower respiratory tract infections in young Gambian children. Int J Epidemiol (1993) 1.99
Chronic poisoning by copper in tap water: II. Copper intoxications with predominantly systemic symptoms. Eur J Med Res (1999) 1.99
Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in The Gambia, West Africa. J Infect Dis (1989) 1.98
Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes. Eur J Immunol (2001) 1.96
Cell-mediated immunity during natural measles infection. J Clin Invest (1978) 1.93
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
Epidemiology of blindness in Nepal. Bull World Health Organ (1985) 1.91
Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet (2000) 1.90
The epidemiology of infections due to Neisseria meningitidis and Neisseria lactamica in a northern Nigerian community. J Infect Dis (1982) 1.89
Polymorphisms in interferon-induced genes and the outcome of hepatitis C virus infection: roles of MxA, OAS-1 and PKR. Genes Immun (2003) 1.88
HLA class I typing by PCR: HLA-B27 and an African B27 subtype. Lancet (1991) 1.86
Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis (1997) 1.86
Seasonal variation of paediatric diseases in The Gambia, west Africa. Ann Trop Paediatr (1993) 1.85
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia. Trans R Soc Trop Med Hyg (1996) 1.84
An evaluation of the informed consent procedure used during a trial of a Haemophilus influenzae type B conjugate vaccine undertaken in The Gambia, West Africa. Soc Sci Med (1999) 1.84
Socio-economic risk factors for malaria in a peri-urban area of The Gambia. Trans R Soc Trop Med Hyg (1995) 1.83
Malaria prevalence is inversely related to vector density in The Gambia, West Africa. Trans R Soc Trop Med Hyg (1995) 1.82
Coronavirus JHM: nucleotide sequence of the mRNA that encodes nucleocapsid protein. Nucleic Acids Res (1983) 1.82
Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs. Infect Immun (2005) 1.81